Study of prevalence of defects in genes of the hemostasis system in patients with reproductive losses in anamnesis. Choosing a rational tactics

Pestrikova T.Yu.; Yurasova E.A.; Vorob’eva A.Yu.

doi:https://doi.org/10.17116/rosakush20222201111

Pestrikova T.Yu.

Far-Eastern State Medical University

Yurasova E.A.

Far-Eastern State Medical University

Vorob’eva A.Yu.

Far Eastern Medical State University

Study of prevalence of defects in genes of the hemostasis system in patients with reproductive losses in anamnesis. Choosing a rational tactics

Authors:

Pestrikova T.Yu., Yurasova E.A., Vorob’eva A.Yu.

More about the authors

Journal: Russian Bulletin of Obstetrician-Gynecologist. 2022;22(1): 11‑20

DOI: 10.17116/rosakush20222201111

Read: 6372 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Pestrikova TYu, Yurasova EA, Vorob’eva AYu. Study of prevalence of defects in genes of the hemostasis system in patients with reproductive losses in anamnesis. Choosing a rational tactics. Russian Bulletin of Obstetrician-Gynecologist. 2022;22(1):11‑20. (In Russ.)
https://doi.org/10.17116/rosakush20222201111

Подписка 2026 Российский вестник акушера-гинеколога (Russian Bulletin of Obstetrician-Gynecologist)

Использование инфографики авторами научных работ

Close metadata

AIM

To study the distribution of genetic defects in the hemostasis system in patients with a history of reproductive losses in order to choose a rational tactics for managing pregnancy.

MATERIAL AND METHODS

The survey included 324 patients of the early reproductive period with a history of reproductive losses. Determination of genetic polymorphisms associated with the risk of thrombophilia was carried out by the method of polymerase chain reaction («DNA-Technology», Moscow). The patients underwent a study of the genotypes of eight distinct genes of the plasma proteins and vascular-platelet compartment of the hemostatic system. Statistical analysis of the obtained results was carried out on the basis of standard methods of medical statistics.

RESULTS

The analysis of the obtained results showed that in 98.77% of patients the presence of mutations in the genes of plasma proteins and vascular-platelet hemostasis was revealed. The frequency of the most dangerous combination of gene mutations that increases the risk of thrombus formation was 42.50% in total. There were simultaneous combinations of defects in the genes of FV Leiden, fibrinogen, α2 and 3β integrin, serpin 1 among them. Mutations were represented by both heterozygous and homozygous forms.

CONCLUSION

An increased tendency to thrombus formation creates conditions for disruption of the processes of implantation, placentation, and fetal growth. Against this background, systemic endothelial dysfunction develops further, the pro-inflammatory response is activated and the procoagulational potential of the blood coagulation system is formed, as a result of which not only thrombotic, but also obstetric complications are realized in carriers of genetic mutations.

Keywords:

defects in genes of the hemostasis system

reproductive losses

Authors:

Pestrikova T.Yu.

Far-Eastern State Medical University

Yurasova E.A.

Far-Eastern State Medical University

Vorob’eva A.Yu.

Far Eastern Medical State University

Received:

02.07.2021

Accepted:

02.08.2021

Close metadata

References:

Simone B, De Stefano V, Leoncini E, Zacho J, Martinelli I, Emmerich J, Rossi E, Folsom AR, Almawi WY, Scarabin PY, den Heijer M, Cushman M, Penco S, Vaya A, Angchaisuksiri P, Okumus G, Gemmati D, Cima S, Akar N, Oguzulgen KI, Ducros V, Lichy C, Fernandez-Miranda C, Szczeklik A, Nieto JA, Torres JD, Cam-Duchez VL, Ivanov P, Cantu-Brito C, Shmeleva VM, Stegnar M, Ogunyemi D, Eid SS, Nicolotti N, De Feo E, Ricciardi W, Boccia S. Risk of venous thromboembolism associated with single and combined effects of factor V Leiden, prothrombin 20210A and methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. Eur J Epidemiol. 2013;28:621-647.
Stevens SM, Woller SC, Bauer KA. Kasthuri R, Cushman M, Streiff M, Lim W, Douketis JD. Guidance for the evaluation and treatment of hereditary and acquired thrombophilia. J Thromb Thrombolysis. 2016;41:1:154-164. https://doi.org/10.1007/s11239-015-1316-1
Gamyrkina DR, Vorob’eva NA. The role of genetic polymorphisms causing hypercoagulability in the problem of recurrent miscarriage. Tromboz, gemostaz i reologiya. 2016;1:65:51-56. (In Russ.).
Bushtyreva IO, Kuznetsova NB, Kovaleva AV, Barinova VV, Sundeeva AG. Prevalence of thrombophilic polymorphisms in women with a history of recurrent miscarriage. Akusherstvo, ginekologiya i reprodutsiya. 2015;2:13-18. (In Russ.). https://doi.org/10.17749/2070-4968.2015.9.2.013-018
Lino FL, Traina É, Barreto JA, Moron AF, Mattar R. Thrombophilic mutations and polymorphisms, alone or in combination, and recurrent spontaneous abortion. Clin Appl Thromb Hemost. 2015;21:4:365-372. https://doi.org/10.1177/1076029613520465
Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GDO, Walker ID, Greaves M, Brenkel I, Regan L, Greer IA, Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thrombophilia in pregnancy: a systematic review. Br J Haematol. 2006;132:2:171-196.
Rodger MA, Walker MC, Smith GN. Wells PS, Ramsay T, Langlois NJ, Carson N, Carrier M, White RR, Shachkina S, Wen SW. Is thrombophilia associated with placenta-mediated pregnancy complications? A prospective cohort study. J Thromb Haemost. 2014;12:4:469-478.
Momot AP, Nikolaeva MG. Genetic thrombophilia and gestational complications. Vestnik gematologii. 2020;XVI:4:4-15. (In Russ.).
Mubinova SV, Mikhailova IV. Clinical case of management of a pregnant woman diagnosed with genetic thrombophilia. Tol’yattinskii meditsinskii konsilium. 2011;1-2:112-114. (In Russ.).
Rapil’bekova GK, Mamedolieva NM. The role of thrombophilia in the syndrome of fetal loss in women of the Kazakh population. Zhurnal akusherstva i zhenskikh boleznei. 2006;LV:3:31-34. (In Russ.).
Baimuradova SM, Slukhanchuk EV. Miscarriage and «criterial» thrombophilia. A modern view of the problem. Sovremennye problemy zdravookhraneniya i meditsinskoi statistiki. 2018;2:94-100. (In Russ.).
Makatsaria A.D. Thrombohemorrhagic complications in obstetric and gynecological practice. M.: Meditsinskoe informatsionnoe agentstvo; 2011;1056. (In Russ.).
Shafey M, Anderson JL, Scarvelis D, Doucette SP, Gagnon F, Wells PS. Factor XIII Val34Leu variant and the risk of myocardial infarction: a meta-analysis. Thromb Haemost. 2007;97:635-641.
Martiskainen M, Pohjasvaara T, Mikkelsson J, Mäntylä R, Kunnas T, Laippala P, Ilveskoski E, Kaste M, Karhunen PJ, Erkinjuntti T. Fibrinogen gene promoter-455 A allele as a risk factor for lacunar stroke. Stroke. 2003;34:4:886-891.
Oszajca K, Wronski K, Janiszewska G, Bienkiewicz M, Panek M, Bartkowiak J, Szemraj J.Association analysis of genetic polymorphisms of factor V, factor VII and fibrinogen? chain genes with human abdominal aortic aneurysm. Exp Ther Med. 2012;4:3:514-518.
Ticconi C, Mancinelli F, Gravina P, Federici G, Piccione E, Bernardini S. Beta-fibrinogen G-455A polymorphisms and recurrent miscarriage. Gynecol Obstet Invest. 2011;71:3:198-201. Epub 2010 Dec 15. https://doi.org/10.1159/000317522
Gerhardt A, Scharf RE, Zotz RB. Effect of hemostatic risk factors on the individual probability of thrombosis during pregnancy and the puerperium. Thromb Haemost. 2003;90:1:77-85.
High risk pregnancy. Ed. Makatsariya A.D., Chervenaka F.A., Bitsadze V.O. M.: Meditsinskoe informatsionnoe agentstvo; 2015;920. (In Russ.).
Arslanbekova MO, Khizroeva DKh. Management of pregnancy and childbirth in a woman with a combined homozygous Leiden mutation and a heterozygous form of prothrombin G20210A. Akusherstvo, ginekologiya i reproduktsiya. 2020;14;1:89-93. (In Russ.).
Pshenichnikova TB, Perederyaeva EB, Makatsaria AD. The effectiveness of pathogenetic therapy in the management of pregnancy in women with metabolic syndrome and thrombophilia. Effektivnaya farmakoterapiya v akusherstve i ginekologii. 2008;4:24-33. (In Russ.).
Makatsariya AD, Bitsadze VO, Akinshina SV. Thromboembolic complications during pregnancy and low molecular weight heparin. Effektivnaya farmakoterapiya v akusherstve i ginekologii. 2009;1:30-43. (In Russ.).
Pestrikova TYu, Porubova YaP. Hereditary forms of thrombophilia in infertile patients entering the ART program. Dal’nevostochnyi meditsinslii zhurnal. 2014;1:119-122. (In Russ.).
Bitsadze VO, Makatsariya AD, Khizroeva DKh, Makatsariya NA, Yashenina EV, Kazakova LA. Thrombophilia as the most important link in the pathogenesis of pregnancy complications. Prakticheskaya meditsina. 2012;5:60:22-29. (In Russ.).
Pestrikova TYu, Shcherbakova OG, Yurasova EA, Knyazeva TP. Experience in managing patients with a history of reproductive loss. Consilium Medicum. 2019;21:6:30-37. (In Russ.).
Khizroeva DKh, Mikhailidi IA, Stuleva NS. The importance of determining protein C in obstetric practice. Prakticheskaya meditsina. 2013;7:52-57. (In Russ.).
Pestrikova TYu, Yurasova EA, Yurasov IV. Modern view of pregravid preparation in patients after past inflammatory diseases of the pelvic organs. Rossiskii vestnik akushera-ginekologa. 2021;21:1:5-10. (In Russ.). https://doi.org/10.17116/rosakush2021210115